R esearch into the CRISPR-Cas immune system of prokaryotes is progressing at a tremendous pace given both its important biological function and its role as a source of new genetic tools. However, a few areas of the field have remained largely unaddressed. A recent report provides information on one such overlooked area: how the cell regulates the CRISPR-Cas immune system. The processes, despite their importance, have remained illusive. In Pectobacterium atrosepticum regulation is, perhaps surprisingly, based on metabolic factors responding to glucose levels in the cell. Regulators include both activators and repressors of cas gene expression. It remains an open question why and how this regulatory system have evolved, and if it is a typical example of how CRISPR-as systems are regulated or not.The CRISPR-Cas system is an adaptive and heritable immune system found in bacteria and archaea. The system comes in different flavors with 5 major types identified so far.1 The CRISPR-Cas systems are based on collecting genetic information from e.g. viruses and plasmids and then storing that information as so-called spacers in the CRISPR locus. The spacer sequences stored in the cell's genome are transcribed and processed into CRISPR RNA (crRNA), these RNA mugshots are then used by CRISPR-associated (Cas) proteins to locate and destroy the matching target.
2,3The discovery of the CRISPR-Cas system adds to our understanding of the complexity of virus-host interaction, one of the key factors in evolution and ecology of life. There is a large interest in the system, both because of its important biological function and its use as a source of tools for genome editing and control of gene expression in eukaryotes. 2,4